The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: a review focus on signaling pathways

AS Doghish, MB Zaki, MG Eldeib, AF Radwan… - … -Research and Practice, 2024 - Elsevier
Colorectal cancer (CRC) is one of the most frequent cancers in incidence and mortality.
Despite advances in cancer biology, molecular genetics, and targeted treatments, CRC …

[HTML][HTML] Mechanism of action and therapeutic implications of Nrf2/HO-1 in inflammatory bowel disease

L Yuan, Y Wang, N Li, X Yang, X Sun, H Tian, Y Zhang - Antioxidants, 2024 - mdpi.com
Oxidative stress (OS) is a key factor in the generation of various pathophysiological
conditions. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) is a major transcriptional …

Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: Novel insights on autophagy, apoptosis, and pyroptosis

R Abdelhady, S Saber… - Frontiers in …, 2023 - frontiersin.org
Ulcerative colitis (UC) is a chronic relapsing inflammatory disease of the colorectal area that
demonstrates a dramatically increasing incidence worldwide. This study provides novel …

[HTML][HTML] Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: insights into the role of TAS …

EA Elmorsy, S Saber, RS Hamad, MA Abdel-Reheim… - Life Sciences, 2024 - Elsevier
Aberrant activation of the NLRP3 inflammasome is recognized to induce a chronic
inflammatory response in the liver, ultimately leading to hepatic fibrosis. HSP90 is suggested …

[HTML][HTML] p-Hydroxy benzaldehyde, a phenolic compound from Nostoc commune, ameliorates DSS-induced colitis against oxidative stress via the Nrf2/HO-1/NQO-1/NF …

M Liu, G Guan, Y Wang, X Lu, X Duan, X Xu - Phytomedicine, 2024 - Elsevier
Background Ulcerative colitis (UC), a chronic idiopathic inflammatory bowel disease (IBD),
presents with limited current drug treatment options. Consequently, the search for safe and …

STA9090 as a potential therapeutic agent for liver fibrosis by modulating the HSP90/TβRII/proteasome interplay: novel insights from in vitro and in vivo investigations

OA Mohammed, MA Abdel-Reheim, MMS Alamri… - Pharmaceuticals, 2023 - mdpi.com
Liver fibrosis is a progressive condition characterized by the build-up of fibrous tissue
resulting from long-term liver injury. Although there have been advancements in research …

Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2/HO-1 antioxidant and inhibiting NF-κB, proinflammatory cytokines and iNOS/NO …

K Amirshahrokhi, M Imani - International Immunopharmacology, 2023 - Elsevier
Ulcerative colitis (UC) is a serious inflammatory disease of the colon. The pathogenic
mechanisms of UC involve the activation of inflammatory and oxidative stress responses in …

New Pyrazole-Clubbed Pyrimidine or Pyrazoline Hybrids as Anti-Methicillin-Resistant Staphylococcus aureus Agents: Design, Synthesis, In Vitro and In Vivo …

B Mansour, MA El-Sherbeny, FAM Al-Omary… - ACS …, 2023 - ACS Publications
Two hybrid series of pyrazole-clubbed pyrimidines 5a–c and pyrazole-clubbed pyrazoline
compounds 6a, b and 7 were designed as attractive scaffolds to be investigated in vitro and …

Mitigation of Dextran-Sodium-Sulfate-Induced Colitis in Mice through Oral Administration of Microbiome-Derived Inosine and Its Underlying Mechanisms

W Guo, X Tang, Q Zhang, J Zhao, B Mao… - International Journal of …, 2023 - mdpi.com
Background: Colonic and serum inosine are significantly reduced in patients with
inflammatory bowel disease (IBD). Methods: This study aimed to explore whether …

Itraconazole halts hepatocellular carcinoma progression by modulating sonic hedgehog signaling in rats: A novel therapeutic approach

OA Mohammed, AS Doghish, LA Saleh… - … -Research and Practice, 2024 - Elsevier
Liver cancer stands as the fourth leading global cause of death, and its prognosis remains
grim due to the limited effectiveness of current medical interventions. Among the various …